Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

Clinical trial NCT07246863 · RECRUITING

Trial details

NCT number: NCT07246863
Sponsor: CatalYm GmbH
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Non-Squamous Non-Small Cell Lung Cancer Adult Solid Tumor

Start date: 2025-10-07
Primary completion: 2029-10-01
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.